Clinical Accelerator

Clinical Accelerator

Pre-clinical

Clinical Accelerator is a lean, execution-focused CRO built to address the unique challenges of early-stage medical device trials. Founded with academic roots, the company combines deep clinical and regulatory expertise with a proven network of high-performing sites to accelerate the clinical development of breakthrough technologies. It has successfully supported over 100 MedTech clients globally, offering a flat operational structure for direct sponsor access and accountability, with a mission to turn innovative ideas into robust clinical evidence efficiently.

Focus
Clinical ResearchDrug Development

AI Company Overview

Clinical Accelerator is a lean, execution-focused CRO built to address the unique challenges of early-stage medical device trials. Founded with academic roots, the company combines deep clinical and regulatory expertise with a proven network of high-performing sites to accelerate the clinical development of breakthrough technologies. It has successfully supported over 100 MedTech clients globally, offering a flat operational structure for direct sponsor access and accountability, with a mission to turn innovative ideas into robust clinical evidence efficiently.

Technology Platform

Operational platform for early-stage medical device trials, featuring a sponsor-aligned CRO model, a dedicated site network in Eastern Europe/Central Asia, and an integrated SMPEO (Site Management, Patient Enrollment, and Operations) approach for predictable execution.

Funding History

2

Total raised: $10M

Series A$8MUndisclosedMay 15, 2022
Grant$2MEuropean CommissionJun 15, 2020

Opportunities

Growth is fueled by the expanding global MedTech innovation sector and the increasing trend towards decentralized clinical trials in strategic regions.
Opportunities exist to become the preferred early-stage CRO for venture-backed device companies and to expand service offerings into adjacent areas like regulatory strategy for its core geographic regions.

Risk Factors

Key risks include geographic concentration in Eastern Europe/Central Asia, dependency on the funding climate for early-stage MedTech clients, and the constant need to maintain flawless execution to protect its reputation in a high-stakes niche.

Competitive Landscape

Competes against large, full-service CROs (less agile for early studies) and other specialized device CROs. Differentiates through an exclusive FIH/EFS focus, a flat, sponsor-aligned operational model, and a strategically built site network in regions offering regulatory and recruitment advantages for early-stage trials.

Company Info

TypeServices
LocationEurope - Other
StagePre-clinical
RevenueRevenue Generating

Therapeutic Areas

CardiovascularOncologyStructural Heart Disease

Partners

HEPTA MedicalAngiolutionsInnovalve BioMedical
SIMILAR COMPANIES
3D BioLabs
3D BioLabs
Pre-clinical · Sarajevo
Bilim Pharmaceuticals
Bilim Pharmaceuticals
Pre-clinical · Istanbul
3Z Pharmaceuticals
3Z Pharmaceuticals
Pre-clinical · Reykjavik
ADAX
ADAX
Pre-clinical · Ljubljana
Exolitus
Exolitus
Pre-clinical · Vienna
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile